Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Markowitz

Showing results (71-80 of 604) with videos related to

Pageof 61
Sort By:
Journal of Clinical Psychopharmacology|June 18, 2008
Differential pharmacokinetics and pharmacodynamics of methylphenidate enantiomers: does chirality matter?John S Markowitz, Kennerly S Patrick
Kidney International Reports|July 19, 2019
Fibrillary Glomerulonephritis: An UpdateJordan L Rosenstock, Glen S Markowitz
Medical Hypotheses|January 9, 1999
Venlafaxine-tramadol similaritiesJ S Markowitz, K S Patrick
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 27, 2012
Increased prevalence of acute interstitial nephritis: more disease or simply more detection?Andrew S Bomback, Glen S Markowitz
Planta Medica|July 21, 2012
Limitations of in vitro assessments of the drug interaction potential of botanical supplementsJohn S Markowitz, Hao-Jie Zhu
Child and Adolescent Psychiatric Clinics of North America|June 13, 2022
The Pharmacokinetics and Pharmacogenomics of PsychostimulantsJohn S Markowitz, Philip W Melchert
The Annals of Pharmacotherapy|December 1, 1996
Pharmacotherapy of dissociative identity disorderJ S Markowitz, H S Gill
Journal of Analytical Toxicology|January 1, 1997
Potential for overestimation of clozapine concentrationsK S Patrick, J S Markowitz
Kidney International|April 2, 2008
Supersized kidneys: Lessons from the preclinical obese kidneyV D D'Agati, G S Markowitz
Clinical Pharmacokinetics|November 15, 2001
Pharmacokinetic and pharmacodynamic drug interactions in the treatment of attention-deficit hyperactivity disorderJ S Markowitz, K S Patrick
Pageof 61

Showing results (71-80 of 604) with videos related to

Sort By:
Pageof 61
Journal of Clinical Psychopharmacology|June 18, 2008
Differential pharmacokinetics and pharmacodynamics of methylphenidate enantiomers: does chirality matter?John S Markowitz, Kennerly S Patrick
Kidney International Reports|July 19, 2019
Fibrillary Glomerulonephritis: An UpdateJordan L Rosenstock, Glen S Markowitz
Medical Hypotheses|January 9, 1999
Venlafaxine-tramadol similaritiesJ S Markowitz, K S Patrick
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 27, 2012
Increased prevalence of acute interstitial nephritis: more disease or simply more detection?Andrew S Bomback, Glen S Markowitz
Planta Medica|July 21, 2012
Limitations of in vitro assessments of the drug interaction potential of botanical supplementsJohn S Markowitz, Hao-Jie Zhu
Child and Adolescent Psychiatric Clinics of North America|June 13, 2022
The Pharmacokinetics and Pharmacogenomics of PsychostimulantsJohn S Markowitz, Philip W Melchert
The Annals of Pharmacotherapy|December 1, 1996
Pharmacotherapy of dissociative identity disorderJ S Markowitz, H S Gill
Journal of Analytical Toxicology|January 1, 1997
Potential for overestimation of clozapine concentrationsK S Patrick, J S Markowitz
Kidney International|April 2, 2008
Supersized kidneys: Lessons from the preclinical obese kidneyV D D'Agati, G S Markowitz
Clinical Pharmacokinetics|November 15, 2001
Pharmacokinetic and pharmacodynamic drug interactions in the treatment of attention-deficit hyperactivity disorderJ S Markowitz, K S Patrick
Pageof 61